TNF and amyotrophic lateral sclerosis: While TNF-α levels are increased in both ALS patients (Poloni et al., 2000) and symptomatic mSOD1 mice (Hensley et al., 2003), deletion of TNF-α did not affect disease progression or microglial activation in mSOD1 mice (Gowing et al., 2006).